Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 3929075, 11 pages
https://doi.org/10.1155/2017/3929075
Research Article

Association of Vitamin D Deficiency and Degree of Coronary Artery Disease in Cardiac Patients with Type 2 Diabetes

1Cardiology Clinic of Physiotherapy Division of the 2nd Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland
2Department of Cardiology, Bielański Hospital, Warsaw, Poland
3Faculty of Health Sciences and Physical Education, Kazimierz Pulaski University of Technology and Humanities, Radom, Poland

Correspondence should be addressed to Jakub S. Gąsior

Received 29 June 2017; Accepted 27 September 2017; Published 2 November 2017

Academic Editor: Suat Simsek

Copyright © 2017 Ewelina A. Dziedzic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. S. Fox, “Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study,” Trends in Cardiovascular Medicine, vol. 20, no. 3, pp. 90–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. Klein, “The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus,” Archives of Internal Medicine, vol. 160, no. 8, pp. 1093–1100, 2000. View at Publisher · View at Google Scholar
  3. K. S. Taylor, C. J. Heneghan, A. J. Farmer et al., “All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database,” Diabetes Care, vol. 36, no. 8, pp. 2366–2371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Das and S. C. Elbein, “The genetic basis of type 2 diabetes,” Cell, vol. 2, no. 4, pp. 100–131, 2006. View at Publisher · View at Google Scholar
  6. J. L. Leahy, “Pathogenesis of type 2 diabetes mellitus,” Archives of Medical Research, vol. 36, no. 3, pp. 197–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Mitri, M. D. Muraru, and A. G. Pittas, “Vitamin D and type 2 diabetes: a systematic review,” European Journal of Clinical Nutrition, vol. 65, no. 9, pp. 1005–1015, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Takiishi, C. Gysemans, R. Bouillon, and C. Mathieu, “Vitamin D and diabetes,” Endocrinology Metabolism Clinics of North America, vol. 39, no. 2, pp. 419–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. G. Pittas, Q. Sun, J. E. Manson, B. Dawson-Hughes, and F. B. Hu, “Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women,” Diabetes Care, vol. 33, no. 9, pp. 2021–2023, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Pittas, J. Lau, F. Hu, and B. Dawson-Hughes, “The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2017–2029, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Liu, J. B. Meigs, A. G. Pittas et al., “Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study,” American Journal of Clinical Nutrition, vol. 91, no. 6, pp. 1627–1633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Grimnes, N. Emaus, R. M. Joakimsen et al., “Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up,” Diabetic Medicine, vol. 27, no. 10, pp. 1107–1115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Gagnon, Z. X. Lu, D. J. Magliano et al., “Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study),” Diabetes Care, vol. 34, no. 5, pp. 1133–1138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Mitri, B. Dawson-Hughes, F. Hu, and A. Pittas, “Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial,” American Journal of Clinical Nutrition, vol. 94, no. 2, pp. 486–494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Xuan, H. Y. Zhao, and J. M. Liu, “Vitamin D and type 2 diabetes mellitus (D2),” Journal of Diabetes, vol. 5, no. 3, pp. 261–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Wolden-Kirk, L. Overbergh, H. T. Christesen, K. Brusgaard, and C. Mathieu, “Vitamin D and diabetes: its importance for beta cell and immune function,” Molecular and Cellular Endocrinology, vol. 347, no. 1-2, pp. 106–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Talaei, M. Mohamadi, and Z. Adgi, “The effect of vitamin D on insulin resistance in patients with type 2 diabetes,” Diabetology & Metabolic Syndrome, vol. 5, no. 1, p. 8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Kostoglou-Athanassiou, P. Athanassiou, A. Gkountouvas, and P. Kaldrymides, “Vitamin D and glycemic control in diabetes mellitus type 2,” Therapeutic Advances in Endocrinology and Metabolism, vol. 4, no. 4, pp. 122–128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Angellotti and A. G. Pittas, “The role of vitamin D in the prevention of type 2 diabetes: to D or not to D?” Endocrinology, vol. 158, no. 7, pp. 2013–2021, 2017. View at Publisher · View at Google Scholar
  20. R. Jorde and Y. Figenschau, “Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels,” European Journal of Nutrition, vol. 48, no. 6, pp. 349–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Zittermann, S. Frisch, H. K. Berthold et al., “Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers,” American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1321–1327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Seida, J. Mitri, I. N. Colmers et al., “Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis,” Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, pp. 3551–3560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. G. Pittas, J. Nelson, J. Mitri et al., “Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program,” Diabetes Care, vol. 35, no. 3, pp. 565–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Witham, F. J. Dove, M. Dryburgh, J. A. Sugden, A. D. Morris, and A. D. Struthers, “The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial,” Diabetologia, vol. 53, no. 10, pp. 2112–2119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Parekh, V. Sarathi, V. K. Shivane, T. R. Bandgar, P. S. Menon, and N. S. Shah, “Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus,” Endocrine Practice, vol. 16, no. 4, pp. 600–608, 2010. View at Publisher · View at Google Scholar
  26. A. U. Koszowska, J. Nowak, A. Dittfeld, A. Brończyk-Puzoń, A. Kulpok, and B. Zubelewicz-Szkodzińska, “Obesity, adipose tissue function and the role of vitamin D,” Central-European Journal of Immunology, vol. 39, no. 2, pp. 260–264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. V. Ramagopalan, A. Heger, A. J. Berlanga et al., “A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution,” Genome Research, vol. 20, no. 10, pp. 1352–1360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. C. Brewer, E. D. Michos, and J. P. Reis, “Vitamin D in atherosclerosis, vascular disease, and endothelial function,” Current Drug Targets, vol. 12, no. 1, pp. 54–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Wacker and M. F. Holick, “Sunlight and vitamin D: a global perspective for health,” Dermatoendocrinology, vol. 5, no. 1, pp. 51–108, 2013. View at Publisher · View at Google Scholar
  30. E. D. Michos and M. L. Melamed, “Vitamin D and cardiovascular disease risk,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 11, no. 1, pp. 7–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. D. Siadat, K. Kiani, M. Sadeghi, A. S. Shariat, Z. Farajzadegan, and M. Kheirmand, “Association of vitamin D deficiency and coronary artery disease with cardiovascular risk factors,” Journal of Research in Medical Sciences, vol. 17, no. 11, pp. 1052–1055, 2012. View at Google Scholar
  32. D. Martins, M. Wolf, D. Pan et al., “Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey,” Archives of Internal Medicine, vol. 167, no. 11, pp. 1159–1165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. D. Thacher and B. L. Clarke, “Vitamin D insufficiency,” Mayo Clinic Proceedings, vol. 86, no. 1, pp. 50–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. E. A. Dziedzic, S. Przychodzeń, and M. Dąbrowski, “The effects of vitamin D on severity of coronary artery atherosclerosis and lipid profile of cardiac patients,” Archives of Medical Science, vol. 12, no. 6, pp. 1199–1206, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 35, Supplement 1, pp. S64–S71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Ashwell, E. M. Stone, H. Stolte et al., “UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status,” The British Journal of Nutrition, vol. 104, no. 4, pp. 603–611, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. L. J. Black, D. Anderson, M. W. Clarke, A. L. Ponsonby, R. M. Lucas, and Ausimmune Investigator Group, “Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D status in clinical and research settings,” PLoS One, vol. 10, no. 8, article e0135478, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Y. Shin, M. J. Kwon, J. Song, H. Park, and H. Y. Woo, “Measurement of serum total vitamin D (25-OH) using automated immunoassay in comparison [corrected] with liquid chromatography tandem-mass spectrometry,” Journal of Clinical Laboratory Analysis, vol. 27, no. 4, pp. 284–289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C. S. Knudsen, E. Nexo, C. S. Højskov, and L. Heickendorff, “Analytical validation of the Roche 25-OH vitamin D total assay,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 11, pp. 1965–1968, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Abdel-Wareth, A. Haq, A. Turner et al., “Total vitamin D assay comparison of the Roche diagnostics “vitamin D total” electrochemiluminescence protein binding assay with the chromsystems HPLC method in a population with both D2 and D3 forms of vitamin D,” Nutrients, vol. 5, no. 3, pp. 971–980, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. O'Neill, A. Kazantzidis, M. J. Ryan et al., “Seasonal changes in vitamin D-effective UVB availability in Europe and associations with population serum 25-Hydroxyvitamin D,” Nutrients, vol. 8, no. 9, p. E533, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Rosecrans and J. C. Dohnal, “Seasonal vitamin D changes and the impact on health risk assessment,” Clinical Biochemistry, vol. 47, no. 7-8, pp. 670–672, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Nair and A. Maseeh, “Vitamin D: the “sunshine” vitamin,” Journal of Pharmacology & Pharmacotherapeutics, vol. 3, no. 2, pp. 118–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Al-Khalidi, S. M. Kimball, M. A. Rotondi, and C. I. Ardern, “Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010,” Nutrition Journal, vol. 16, no. 1, p. 16, 2017. View at Publisher · View at Google Scholar
  45. I. Ringqvist, L. D. Fisher, M. Mock et al., “Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS),” The Journal of Clinical Investigation, vol. 71, no. 6, pp. 1854–1866, 1983. View at Publisher · View at Google Scholar
  46. S. E. Judd and V. Tangpricha, “Vitamin D deficiency and risk for cardiovascular disease,” American Journal of the Medical Sciences, vol. 338, no. 1, pp. 40–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. K. E. Watson, M. L. Abrolat, L. L. Malone et al., “Active serum vitamin D levels are inversely correlated with coronary calcification,” Circulation, vol. 96, no. 6, pp. 1755–1760, 1997. View at Publisher · View at Google Scholar
  48. D. Papandreou and Z. T. Hamid, “The role of vitamin D in diabetes and cardiovascular disease: an updated review of the literature,” Disease Markers, vol. 2015, Article ID 580474, 15 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. B. J. Boucher, “Vitamin D insufficiency and diabetes risks,” Current Drug Targets, vol. 12, no. 1, pp. 61–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Laakso, “Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008,” Diabetes Care, vol. 33, no. 2, pp. 442–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Tousoulis, A. M. Kampoli, N. Papageorgiou, S. Papaoikonomou, C. Antoniades, and C. Stefanadis, “The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches,” Current Pharmaceutical Design, vol. 15, no. 17, pp. 2037–2048, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. A joint editorial statement by the American Diabetes Association, “The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Diabetes mellitus: a major risk factor for cardiovascular disease,” Circulation, vol. 100, no. 10, pp. 1132-1133, 1999. View at Publisher · View at Google Scholar
  53. F. B. Hu, M. J. Stampfer, C. G. Solomon et al., “The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women : 20 years of follow-up,” Archives of Internal Medicine, vol. 161, no. 14, pp. 1717–1723, 2001. View at Publisher · View at Google Scholar
  54. P. Płudowski, C. Ducki, J. Konstantynowicz, and M. Jaworski, “Vitamin D status in Poland,” Polish Archives of Internal Medicine, vol. 126, no. 7-8, pp. 530–539, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. E. A. Yetley, “Assessing the vitamin D status of the US population,” The American Journal of Clinical Nutrition, vol. 88, pp. 558S–564S, 2008. View at Google Scholar
  56. A. Zadshir, N. Tareen, D. Pan, K. Norris, and D. Martins, “The prevalence of hypovitaminosis D among US adults: data from the NHANES III,” Ethnicity & Disease, vol. 15, Supplement 5, no. 4, pp. S5-97–S5101, 2005. View at Google Scholar
  57. A. L. Schneider, P. L. Lutsey, E. Selvin et al., “Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study,” European Journal of Neurology, vol. 22, no. 8, pp. 1220–1227, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. E. D. Michos, J. R. Misialek, E. Selvin et al., “25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study,” Atherosclerosis, vol. 241, no. 1, pp. 12–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. A. B. Connell, N. Jenkins, M. Black, J. A. Pasco, M. A. Kotowicz, and H. G. Schneider, “Overreporting of vitamin D deficiency with the Roche Elecsys vitamin D3 (25-OH) method,” Pathology, vol. 43, no. 4, pp. 368–371, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Kmieć, M. Żmijewski, P. Waszak, K. Sworczak, and M. Lizakowska-Kmieć, “Vitamin D deficiency during winter months among an adult, predominantly urban, population in Northern Poland,” Endokrynologia Polska, vol. 65, no. 2, pp. 105–113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. A. V. Finn and R. K. Jain, “Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization?” JACC. Cardiovascular Imaging, vol. 3, no. 1, pp. 41–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Camaré, M. Pucelle, A. Nègre-Salvayre, and R. Salvayre, “Angiogenesis in the atherosclerotic plaque,” Redox Biology, vol. 12, pp. 18–34, 2017. View at Publisher · View at Google Scholar
  63. H. Al Shahi, K. Shimada, K. Miyauchi et al., “Elevated circulating levels of inflammatory markers in patients with acute coronary syndrome,” International Journal of Vascular Medicine, vol. 2015, Article ID 805375, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. P. M. Timms, N. Mannan, G. A. Hitman et al., “Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?” QJM, vol. 95, no. 12, pp. 787–796, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Ohsawa, T. Koyama, K. Yamamoto, S. Hirosawa, S. Kamei, and R. Kamiyama, “1α,25-Dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL,” Circulation, vol. 102, no. 23, pp. 2867–2872, 2000. View at Publisher · View at Google Scholar
  66. T. Koyama, M. Shibakura, M. Ohsawa, R. Kamiyama, and S. Hirosawa, “Anticoagulant effects of 1α,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes,” Blood, vol. 92, no. 1, pp. 160–167, 1998. View at Google Scholar
  67. M. Cumhur Cure, E. Cure, S. Yuce, T. Yazici, I. Karakoyun, and H. Efe, “Mean platelet volume and vitamin D level,” Annals of Laboratory Medicine, vol. 34, no. 2, pp. 98–103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Gondim, A. Caribé, K. F. Vasconcelos, A. D. Segundo, and F. Bandeira, “Vitamin D deficiency is associated with severity of acute coronary syndrome in patients with type 2 diabetes and high rates of sun exposure,” Clinical Medicine Insights. Endocrinology and Diabetes, vol. 9, pp. 37–41, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. L. C. Correia, F. Sodré, G. Garcia et al., “Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes,” The American Journal of Cardiology, vol. 111, no. 3, pp. 324–327, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Joergensen, H. Reinhard, A. Schmedes et al., “Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate,” Diabetes Care, vol. 35, no. 1, pp. 168–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. B. O'Hartaigh, G. Neil Thomas, G. Silbernagel et al., “Association of 25-hydroxyvitamin D with type 2 diabetes among patients undergoing coronary angiography: crosssectional findings from the LUdwigshafen Risk and Cardiovascular Health (LURIC) Study,” Clinical Endocrinology, vol. 79, no. 2, pp. 192–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Y. Forrest and W. L. Stuhldreher, “Prevalence and correlates of vitamin D deficiency in US adults,” Nutrition Research, vol. 31, no. 1, pp. 48–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. K. A. Kennel, M. T. Drake, and D. L. Hurley, “Vitamin D deficiency in adults: when to test and how to treat,” Mayo Clinic Proceedings, vol. 85, no. 8, pp. 752–757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. Q. J. Khan and C. J. Fabian, “How I treat vitamin D deficiency,” Journal of Oncology Practice, vol. 6, no. 2, pp. 97–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. T. F. Whayne Jr, “Vitamin D: popular cardiovascular supplement but benefit must be evaluated,” International Journal of Angiology, vol. 20, no. 2, pp. 63–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Y. Lee, T. Y. So, and J. Thackray, “A review on vitamin D deficiency treatment in pediatric patients,” Journal of Pediatric Pharmacology and Therapeutics, vol. 18, no. 4, pp. 277–291, 2013. View at Publisher · View at Google Scholar
  77. T. Kühn, “Vitamin D deficiency in urban Poland: what are the implications?” Polish Archives of Internal Medicine, vol. 126, no. 7-8, pp. 468–470, 2016. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Anagnostis, V. G. Athyros, F. Adamidou, M. Florentin, and A. Karagiannis, “Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?” Current Vascular Pharmacology, vol. 8, no. 5, pp. 720–730, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. M. F. Holick, “The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention,” Reviews in Endocrine & Metabolic Disorders, vol. 18, no. 2, pp. 153–165, 2017. View at Publisher · View at Google Scholar
  80. P. Pludowski, M. F. Holick, W. B. Grant et al., “Vitamin D supplementation guidelines,” Journal of Steroid Biochemistry and Molecular Biology, vol. S0960-0760, no. 17, pp. 30031–30036, 2017. View at Publisher · View at Google Scholar
  81. A. G. Pittas, S. S. Harris, P. C. Stark, and B. Dawson-Hughes, “The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults,” Diabetes Care, vol. 30, no. 4, pp. 980–986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. A. G. Pittas, B. Dawson-Hughes, P. R. Sheehan et al., “Rationale and design of the vitamin D and type 2 diabetes (D2d) study: a diabetes prevention trial,” Diabetes Care, vol. 37, no. 12, pp. 3227–3234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. C. J. Lee, G. Iyer, Y. Liu et al., “The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis of intervention studies,” Journal of Diabetes and its Complications, vol. 31, no. 7, pp. 1115–1126, 2017. View at Publisher · View at Google Scholar
  84. C. Wu, S. Qiu, X. Zhu, and L. Li, “Vitamin D supplementation and glycemic control in type 2 diabetes patients: a systematic review and meta-analysis,” Metabolism, vol. 73, pp. 67–76, 2017. View at Publisher · View at Google Scholar